Portfolio company
STENTiT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VenoStent
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
DRUG-COATED BALLOON (DCB)
This company develops nanoparticle-based dual-drug-coated balloons for interventional cardiologists to treat coronary and peripheral artery disease without permanent implants.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Intelvasc
This company develops implantable sensors and monitoring systems to track blood flow and vascular occlusions for patients with peripheral arterial disease.
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
Nitiloop
Nitiloop develops vascular microcatheters for cardiologists and surgeons to treat chronic total occlusions and other complex lesions within coronary and peripheral vasculature.
Intact Vascular
The company develops minimally invasive medical devices for treating peripheral artery disease and post-angioplasty dissections in patients and clinicians.
